{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:40:46Z","timestamp":1792514446199,"version":"4.5.0"},"reference-count":140,"publisher":"Elsevier BV","issue":"349","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T00:00:00Z","timestamp":1651795200000},"content-version":"am","delay-in-days":339,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Morphologie"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.morpho.2020.11.008","type":"journal-article","created":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T10:31:52Z","timestamp":1606991512000},"page":"170-187","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Medication-related osteonecrosis and osteoradionecrosis of the jaws: Update and current management"],"prefix":"10.1016","volume":"105","author":[{"given":"J.-D.","family":"K\u00fcn-Darbois","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Fauvel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.morpho.2020.11.008_bib0705","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.joms.2005.01.010","article-title":"Bisphosphonate osteochemonecrosis (bis-phossy jaw): is this phossy jaw of the 21st century?","volume":"63","author":"Hellstein","year":"2005","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.morpho.2020.11.008_bib0710","first-page":"371","article-title":"Necrosis of the jaw in workers employed in applying a luminous paint containing radium","volume":"7","author":"Castle","year":"1925","journal-title":"J Industr Hyg"},{"key":"10.1016\/j.morpho.2020.11.008_bib0715","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41413-020-0088-1","article-title":"Mitigating osteonecrosis of the jaw (ONJ) through preventive dental care and understanding of risk factors","volume":"8","author":"Wan","year":"2020","journal-title":"Bone Res"},{"key":"10.1016\/j.morpho.2020.11.008_bib0720","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3109\/00016922609139503","article-title":"Radiation osteitis","volume":"6","author":"Eiving","year":"1926","journal-title":"Acta Radiol"},{"key":"10.1016\/j.morpho.2020.11.008_bib0725","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jormas.2019.12.003","article-title":"Positive effect of pentoxifylline on medication-related osteonecrosis of the jaw","volume":"121","author":"Li","year":"2020","journal-title":"J Stomatol Oral Maxillofac Surg"},{"key":"10.1016\/j.morpho.2020.11.008_bib0730","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.morpho.2020.11.008_bib0735","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.joms.2009.10.010","article-title":"Osteonecrosis of the jaw in a patient on denosumab","volume":"68","author":"Aghaloo","year":"2010","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.morpho.2020.11.008_bib0740","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00198-010-1177-6","article-title":"Denosumab-related osteonecrosis of the jaws","volume":"22","author":"Kyrgidis","year":"2011","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.morpho.2020.11.008_bib0745","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.bjoms.2019.09.023","article-title":"Osteonecrosis and osteomyelitis of the jaw associated with tumour necrosis factor-alpha (TNF-alpha) inhibitors: a systematic review","volume":"58","author":"Sacco","year":"2020","journal-title":"Br J Oral Maxillofac Surg"},{"key":"10.1016\/j.morpho.2020.11.008_bib0750","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw \u2014 2014 update","volume":"72","author":"Ruggiero","year":"2014","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.morpho.2020.11.008_bib0755","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ctrv.2018.06.007","article-title":"Medication-related osteonecrosis of the jaw: prevention, diagnosis and management in patients with cancer and bone metastases","volume":"69","author":"Otto","year":"2018","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.morpho.2020.11.008_bib0760","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.4317\/medoral.23191","article-title":"Review and update on drugs related to the development of osteonecrosis of the jaw","volume":"25","author":"Eguia","year":"2020","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"10.1016\/j.morpho.2020.11.008_bib0765","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1200\/JCO.19.01186","article-title":"Medication-related osteonecrosis of the jaw: MASCC\/ISOO\/ASCO clinical practice guideline","volume":"37","author":"Yarom","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.morpho.2020.11.008_bib0770","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.bone.2011.04.022","article-title":"Bisphosphonates: the first 40 years","volume":"49","author":"Russell","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.morpho.2020.11.008_bib0775","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jbmr.2405","article-title":"Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus","volume":"30","author":"Khan","year":"2015","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.morpho.2020.11.008_bib0780","first-page":"1099","article-title":"A systematic review of bisphosphonate osteonecrosis (BON) in cancer","volume":"18","author":"Migliorati","year":"2010","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.morpho.2020.11.008_bib0785","doi-asserted-by":"crossref","first-page":"753","DOI":"10.7326\/0003-4819-144-10-200605160-00009","article-title":"Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws","volume":"144","author":"Woo","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.morpho.2020.11.008_bib0790","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s10006-017-0667-5","article-title":"Differences between osteoradionecrosis and medication-related osteonecrosis of the jaw","volume":"22","author":"Akashi","year":"2018","journal-title":"Oral Maxillofac Surg"},{"key":"10.1016\/j.morpho.2020.11.008_bib0795","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1016\/j.ijom.2016.06.016","article-title":"Osteoradionecrosis and medication-related osteonecrosis of the jaw: similarities and differences","volume":"45","author":"Grisar","year":"2016","journal-title":"Int J Oral Maxillofac Surg"},{"key":"10.1016\/j.morpho.2020.11.008_bib0800","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1007\/s00784-018-2385-2","article-title":"Bone mineralisation and vascularisation in bisphosphonate-related osteonecrosis of the jaw: an experimental study in the rat","volume":"22","author":"Kun-Darbois","year":"2018","journal-title":"Clin Oral Investig"},{"key":"10.1016\/j.morpho.2020.11.008_bib0805","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1746-1596-7-78","article-title":"Bisphosphonate-related osteonecrosis of jaw (BRONJ): an anti-angiogenic side effect?","volume":"7","author":"Petcu","year":"2012","journal-title":"Diagnos Pathol"},{"key":"10.1016\/j.morpho.2020.11.008_bib0810","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s00784-013-1060-x","article-title":"Bisphosphonates\u2019 antiangiogenic potency in the development of bisphosphonate-associated osteonecrosis of the jaws: influence on microvessel sprouting in an in vivo 3D Matrigel assay","volume":"18","author":"Pabst","year":"2014","journal-title":"Clin Oral Invest"},{"key":"10.1016\/j.morpho.2020.11.008_bib0815","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2045-824X-5-1","article-title":"Bisphosphonate-related osteonecrosis of jaw (BRONJ): diagnostic criteria and possible pathogenic mechanisms of an unexpected anti-angiogenic side effect","volume":"5","author":"Sharma","year":"2013","journal-title":"Vasc Cell"},{"key":"10.1016\/j.morpho.2020.11.008_bib0820","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.bone.2010.09.035","article-title":"Nitrogen-containing bisphosphonates can inhibit angiogenesis in vivo without the involvement of farnesyl pyrophosphate synthase","volume":"48","author":"Stresing","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.morpho.2020.11.008_bib0825","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.tripleo.2011.02.028","article-title":"Differential impairment of vascularisation and angiogenesis in bisphosphonate-associated osteonecrosis of the jaw-related mucoperiosteal tissue","volume":"112","author":"Wehrhan","year":"2011","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.morpho.2020.11.008_bib0830","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00223-003-0042-4","article-title":"Risedronate rapidly reduces the risk for non-vertebral fractures in women with postmenopausal osteoporosis","volume":"74","author":"Harrington","year":"2004","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.morpho.2020.11.008_bib0835","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/PL00004171","article-title":"Multinational, placebo-controlled, randomised trial of the effects of alendronate on bone density and fracture risk in postmenopausal women with low bone mass: results of the FOSIT study. Fosamax International Trial Study Group","volume":"9","author":"Pols","year":"1999","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.morpho.2020.11.008_bib0840","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1002\/cncr.23783","article-title":"A multicentre, randomised clinical trial comparing zoledronic acid versus observation in patients with asymptomatic myeloma","volume":"113","author":"Musto","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.morpho.2020.11.008_bib0845","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2174\/187152012799014986","article-title":"Bisphosphonate anticancer activity in multiple myeloma","volume":"12","author":"Terpos","year":"2012","journal-title":"Anticancer Agents Med Chem"},{"key":"10.1016\/j.morpho.2020.11.008_bib0850","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1056\/NEJM199702203360807","article-title":"The management of Paget's disease of bone","volume":"336","author":"Delmas","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.morpho.2020.11.008_bib0855","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0749-0690(02)00069-1","article-title":"Bisphosphonate treatment of osteoporosis","volume":"19","author":"Watts","year":"2003","journal-title":"Clin Geriatr Med"},{"key":"10.1016\/j.morpho.2020.11.008_bib0860","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1210\/jc.2013-1597","article-title":"The effect of three or six years of denosumab exposure in women with postmenopausal osteoporosis: results from the FREEDOM extension","volume":"98","author":"Bone","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.morpho.2020.11.008_bib0865","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S2213-8587(17)30138-9","article-title":"10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension","volume":"5","author":"Bone","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.morpho.2020.11.008_bib0870","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1210\/jc.2010-2784","article-title":"Treatment with denosumab reduces the incidence of new vertebral and hip fractures in postmenopausal women at high risk","volume":"96","author":"Boonen","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.morpho.2020.11.008_bib0875","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"Denosumab for prevention of fractures in postmenopausal women with osteoporosis","volume":"361","author":"Cummings","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.morpho.2020.11.008_bib0880","doi-asserted-by":"crossref","first-page":"115268","DOI":"10.1016\/j.bone.2020.115268","article-title":"Denosumab in postmenopausal women with osteoporosis and diabetes: subgroup analysis of FREEDOM and FREEDOM extension","volume":"134","author":"Ferrari","year":"2020","journal-title":"Bone"},{"key":"10.1016\/j.morpho.2020.11.008_bib0885","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1210\/jc.2016-1801","article-title":"Denosumab or zoledronic acid in postmenopausal women with osteoporosis previously treated with oral bisphosphonates","volume":"101","author":"Miller","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.morpho.2020.11.008_bib0890","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1016\/j.ejca.2015.05.016","article-title":"Hypocalcaemia in patients with metastatic bone disease treated with denosumab","volume":"51","author":"Body","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.morpho.2020.11.008_bib0895","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0140-6736(10)62344-6","article-title":"Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double blind study","volume":"377","author":"Fizazi","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.morpho.2020.11.008_bib0900","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejca.2015.09.011","article-title":"Effect of denosumab versus zoledronic acid in preventing skeletal-related events in patients with bone metastases by baseline characteristics","volume":"53","author":"Lipton","year":"2016","journal-title":"Eur J Cancer"},{"issue":"Suppl 2","key":"10.1016\/j.morpho.2020.11.008_bib0905","first-page":"e679","article-title":"Jaw bone samples from bisphosphonate-treated patients: a pilot cohort study","volume":"17","author":"Cardemil","year":"2015","journal-title":"Clin Implant Dent Relat Res"},{"key":"10.1016\/j.morpho.2020.11.008_bib0910","doi-asserted-by":"crossref","first-page":"471035","DOI":"10.1155\/2014\/471035","article-title":"Bisphosphonate associated osteonecrosis of the jaw: an update on pathophysiology, risk factors, and treatment","volume":"2014","author":"Rasmusson","year":"2014","journal-title":"Int J Dent"},{"key":"10.1016\/j.morpho.2020.11.008_bib0915","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jormas.2017.06.012","article-title":"Update MRONJ and perspectives of its treatment","volume":"118","author":"Voss","year":"2017","journal-title":"J Stomatol Oral Maxillofac Surg"},{"key":"10.1016\/j.morpho.2020.11.008_bib0920","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1747-4477.2009.00213.x","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaw \u2013 2009 update","volume":"35","author":"Ruggiero","year":"2009","journal-title":"Aust Endod J"},{"key":"10.1016\/j.morpho.2020.11.008_bib0925","doi-asserted-by":"crossref","first-page":"1","DOI":"10.11005\/jbm.2015.22.1.1","article-title":"Pathogenesis, management and prevention of atypical femoral fractures","volume":"22","author":"Im","year":"2015","journal-title":"J Bone Metab"},{"key":"10.1016\/j.morpho.2020.11.008_bib0930","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.bone.2007.04.196","article-title":"Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity?","volume":"41","author":"Reid","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.morpho.2020.11.008_bib0935","doi-asserted-by":"crossref","first-page":"31604","DOI":"10.1038\/srep31604","article-title":"The association of medication-related osteonecrosis of the jaw with Actinomyces spp. infection","volume":"6","author":"Russmueller","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.morpho.2020.11.008_bib0940","doi-asserted-by":"crossref","first-page":"4925","DOI":"10.3390\/ijms20194925","article-title":"From osteoclast differentiation to osteonecrosis of the jaw: molecular and clinical insights","volume":"20","author":"Anesi","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.morpho.2020.11.008_bib0945","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jcms.2020.01.005","article-title":"Saliva diagnostics in patients suffering from bisphosphonate-associated osteonecrosis of the jaw: results of an observational study","volume":"48","author":"Stockmann","year":"2020","journal-title":"J Cranio-Maxillofac Surg"},{"key":"10.1016\/j.morpho.2020.11.008_bib0950","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.joms.2009.01.007","article-title":"The pathogenesis of bisphosphonate-related osteonecrosis of the jaw: so many hypotheses, so few data","volume":"67","author":"Allen","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.morpho.2020.11.008_bib0955","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.coms.2015.06.004","article-title":"The role of antiangiogenic therapy in the development of osteonecrosis of the jaw","volume":"27","author":"Fantasia","year":"2015","journal-title":"Oral Maxillofac Surg Clin"},{"key":"10.1016\/j.morpho.2020.11.008_bib0960","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ijom.2019.07.016","article-title":"Pharmacogenetics of medication-related osteonecrosis of the jaw: a systematic review and meta-analysis","volume":"49","author":"Guo","year":"2020","journal-title":"Int J Oral Maxillofac Surg"},{"key":"10.1016\/j.morpho.2020.11.008_bib0965","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.coms.2015.06.005","article-title":"Pharmacogenetics of bisphosphonate-associated osteonecrosis of the jaw","volume":"27","author":"Fung","year":"2015","journal-title":"Oral Maxillofac Surg Clin North Am"},{"key":"10.1016\/j.morpho.2020.11.008_bib0970","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.ijom.2011.02.002","article-title":"Genetic polymorphisms and other risk factors associated with bisphosphonate induced osteonecrosis of the jaw","volume":"40","author":"Katz","year":"2011","journal-title":"Int J Oral Maxillofac Surg"},{"key":"10.1016\/j.morpho.2020.11.008_bib0975","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1634\/theoncologist.2011-0202","article-title":"Genomewide pharmacogenetics of bisphosphonate-induced osteonecrosis of the jaw: the role of RBMS3","volume":"17","author":"Nicoletti","year":"2012","journal-title":"Oncologist"},{"key":"10.1016\/j.morpho.2020.11.008_bib0980","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.bone.2019.04.010","article-title":"Pharmacogenomics of osteonecrosis of the jaw","volume":"124","author":"Yang","year":"2019","journal-title":"Bone"},{"key":"10.1016\/j.morpho.2020.11.008_bib0985","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.bjoms.2016.05.025","article-title":"Search for a reliable model for bisphosphonate-related osteonecrosis of the jaw: establishment of a model in pigs and description of its histomorphometric characteristics","volume":"54","author":"Mitsimponas","year":"2016","journal-title":"Br J Oral Maxillofac Surg"},{"key":"10.1016\/j.morpho.2020.11.008_bib0990","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.oraloncology.2007.11.012","article-title":"Bisphosphonate-induced osteonecrosis of the jaws: prospective study of 80 patients with multiple myeloma and other malignancies","volume":"44","author":"Boonyapakorn","year":"2008","journal-title":"Oral Oncol"},{"key":"10.1016\/j.morpho.2020.11.008_bib0995","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1016\/j.joms.2007.08.003","article-title":"Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment","volume":"65","author":"Marx","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.morpho.2020.11.008_bib1000","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.joms.2005.07.010","article-title":"Bisphosphonate-induced exposed bone (osteonecrosis\/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment","volume":"63","author":"Marx","year":"2005","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.morpho.2020.11.008_bib1005","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.joms.2009.02.004","article-title":"Clinical investigation of C-terminal cross-linking telopeptide test in prevention and management of bisphosphonate-associated osteonecrosis of the jaws","volume":"67","author":"Kunchur","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.morpho.2020.11.008_bib1010","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1308\/rcsfdj.2014.5.2.90","article-title":"Osteonecrosis of the jaw: BRONJ and ARONJ","volume":"5","author":"Ruggiero","year":"2014","journal-title":"Fac Dent J"},{"key":"10.1016\/j.morpho.2020.11.008_bib1015","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.ijom.2012.06.020","article-title":"Increased incidence of osteonecrosis of the jaw after tooth extraction in patients treated with bisphosphonates: a cohort study","volume":"41","author":"Yamazaki","year":"2012","journal-title":"Int J Oral Maxillofac Surg"},{"key":"10.1016\/j.morpho.2020.11.008_bib1020","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1111\/clr.12526","article-title":"What is the impact of bisphosphonate therapy upon dental implant survival? A systematic review and meta-analysis","volume":"27","author":"Ata-Ali","year":"2016","journal-title":"Clin Oral Implants Res"},{"key":"10.1016\/j.morpho.2020.11.008_bib1025","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jdent.2012.12.008","article-title":"Dental implants in the medically compromised patient","volume":"41","author":"Diz","year":"2013","journal-title":"J Dent"},{"key":"10.1016\/j.morpho.2020.11.008_bib1030","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/clr.12088","article-title":"Osteonecrosis associated with dental implants in patients undergoing bisphosphonate treatment","volume":"25","author":"Kwon","year":"2014","journal-title":"Clin Oral Implants Res"},{"issue":"4","key":"10.1016\/j.morpho.2020.11.008_bib1035","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1097\/SCS.0000000000006283","article-title":"Surgical management of medication-related osteonecrosis of the jaw patients related to dental implants","volume":"31","author":"Nisi","year":"2020","journal-title":"J Craniofac Surg"},{"key":"10.1016\/j.morpho.2020.11.008_bib1040","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jormas.2019.04.012","article-title":"Medication-related osteonecrosis of the jaw. Implant presence-triggered osteonecrosis: case series and literature review","volume":"121","author":"Escobedo","year":"2020","journal-title":"J Stomatol Oral Maxillofac Surg"},{"key":"10.1016\/j.morpho.2020.11.008_bib1045","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/jop.12963","article-title":"Association between periodontitis and medication-related osteonecrosis of the jaw: a systematic review and meta-analysis","volume":"49","author":"Lorenzo-Pouso","year":"2020","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.morpho.2020.11.008_bib1050","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.4317\/jced.56265","article-title":"Tomographic study of jaw bone changes in patients with bisphosphonate-related osteonecrosis","volume":"12","author":"Simpione","year":"2020","journal-title":"J Clin Exp Dent"},{"key":"10.1016\/j.morpho.2020.11.008_bib1055","doi-asserted-by":"crossref","first-page":"5356","DOI":"10.1200\/JCO.2009.21.9584","article-title":"Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw","volume":"27","author":"Vahtsevanos","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.morpho.2020.11.008_bib1060","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.joms.2008.12.002","article-title":"Imaging findings in bisphosphonate-related osteonecrosis of jaws","volume":"67","author":"Arce","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"issue":"3","key":"10.1016\/j.morpho.2020.11.008_bib1065","first-page":"505","article-title":"Awareness about medication-related osteonecrosis of the jaw among dental professionals: a multicentre study","volume":"18","author":"Patil","year":"2020","journal-title":"Oral Health Prev Dent"},{"key":"10.1016\/j.morpho.2020.11.008_bib1070","first-page":"1","article-title":"Current knowledge regarding medication-related osteonecrosis of the jaw among different health professionals","author":"Miranda-Silva","year":"2020","journal-title":"Support Care Cancer"},{"issue":"4","key":"10.1016\/j.morpho.2020.11.008_bib1075","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jormas.2019.10.005","article-title":"Medical students\u2019 knowledge of medication related osteonecrosis of the jaw","volume":"121","author":"Franchi","year":"2020","journal-title":"J Stomatol Oral Maxillofac Surg"},{"key":"10.1016\/j.morpho.2020.11.008_bib1080","series-title":"Ost\u00e9on\u00e9crose des m\u00e2choires en chirurgie oromaxillofaciale et traitements m\u00e9dicamenteux \u00e0 risque (antir\u00e9sorbeurs osseux, antiangiog\u00e9niques). Recommandations de bonne pratique","author":"Soci\u00e9t\u00e9 fran\u00e7aise de stomatologie chirurgie maxillo-faciale et chirurgie orale","year":"2013"},{"key":"10.1016\/j.morpho.2020.11.008_bib1085","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/annonc\/mdn554","article-title":"Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid","volume":"20","author":"Dimopoulos","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.morpho.2020.11.008_bib1090","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/annonc\/mdn526","article-title":"Decreased occurrence of osteonecrosis of the jaw after implementation of dental preventive measures in solid tumour patients with bone metastases treated with bisphosphonates. The experience of the National Cancer Institute of Milan","volume":"20","author":"Ripamonti","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.morpho.2020.11.008_bib1095","first-page":"b147","article-title":"Preventive strategies and clinical implications for bisphosphonate-related osteonecrosis of the jaw: a review of 282 patients","volume":"77","author":"Bonacina","year":"2011","journal-title":"J Can Dent Assoc"},{"key":"10.1016\/j.morpho.2020.11.008_bib1100","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/annonc\/mdr039","article-title":"Impact of dental care in the prevention of bisphosphonate-associated osteonecrosis of the jaw: a single-centre clinical experience","volume":"23","author":"Vandone","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.morpho.2020.11.008_bib1105","first-page":"33","article-title":"Bisphosphonate-related osteonecrosis of the jaws: a potential alternative to drug holidays","volume":"61","author":"Damm","year":"2013","journal-title":"Gen Dent"},{"key":"10.1016\/j.morpho.2020.11.008_bib1110","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.bone.2010.11.020","article-title":"Denosumab and bisphosphonates: different mechanisms of action and effects","volume":"48","author":"Baron","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.morpho.2020.11.008_bib1115","first-page":"220","article-title":"Primary wound closure and perioperative antibiotic therapy for prevention of bisphosphonate-related osteonecrosis of the jaw after tooth extraction","volume":"51","author":"Spanou","year":"2020","journal-title":"Quintessence Int"},{"key":"10.1016\/j.morpho.2020.11.008_bib1120","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.jcms.2020.02.006","volume":"48","author":"Poxleitner","year":"2020","journal-title":"J Cranio-Maxillofac Surg"},{"issue":"10","key":"10.1016\/j.morpho.2020.11.008_bib1125","article-title":"Interventions for managing medication-related osteonecrosis of the jaw","author":"Beth-Tasdogan","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.morpho.2020.11.008_bib1130","series-title":"Recommandations de bonne paratique \u2013 Implants dentaires et bisphosphonates. 26e journ\u00e9e scientifique du GRIO","author":"Ruhin","year":"2013"},{"key":"10.1016\/j.morpho.2020.11.008_bib1135","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1002\/jbmr.2525","article-title":"Comments on \u201cdiagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus\u201d","volume":"30","author":"Otto","year":"2015","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.morpho.2020.11.008_bib1140","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1111\/odi.13160","article-title":"Workshop of European task force on medication-related osteonecrosis of the jaw \u2013 current challenges","volume":"25","author":"Schiodt","year":"2019","journal-title":"Oral Dis"},{"key":"10.1016\/j.morpho.2020.11.008_bib1145","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.oraloncology.2014.08.016","article-title":"A systematic review of therapeutical approaches in bisphosphonates-related osteonecrosis of the jaw (BRONJ)","volume":"50","author":"Rupel","year":"2014","journal-title":"Oral Oncol"},{"key":"10.1016\/j.morpho.2020.11.008_bib1150","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.joms.2013.12.007","article-title":"Management of antiresorptive osteonecrosis of the jaws with primary surgical resection","volume":"72","author":"Carlson","year":"2014","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.morpho.2020.11.008_bib1155","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.joms.2009.01.006","article-title":"The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws","volume":"67","author":"Carlson","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.morpho.2020.11.008_bib1160","article-title":"Medication-related osteonecrosis of the jaw (MRONJ) stage III: conservative and conservative surgical approaches versus an aggressive surgical intervention: a systematic review","author":"Jasper","year":"2020","journal-title":"J Cranio-Maxillofac Surg"},{"key":"10.1016\/j.morpho.2020.11.008_bib1165","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.jcms.2013.05.038","article-title":"Successful surgical management of osteonecrosis of the jaw due to RANK-ligand inhibitor treatment using fluorescence guided bone resection","volume":"41","author":"Otto","year":"2013","journal-title":"J Cranio-Maxillofac Surg"},{"key":"10.1016\/j.morpho.2020.11.008_bib1170","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/j.jcms.2019.07.012","article-title":"Fluorescence-guided bone resection: a histological analysis in medication-related osteonecrosis of the jaw","volume":"47","author":"Wehrhan","year":"2019","journal-title":"J Cranio-Maxillofac Surg"},{"key":"10.1016\/j.morpho.2020.11.008_bib1175","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1002\/lary.21062","article-title":"Outcomes of vascularised bone graft reconstruction of the mandible in bisphosphonate-related osteonecrosis of the jaws","volume":"120","author":"Seth","year":"2010","journal-title":"Laryngoscope"},{"key":"10.1016\/j.morpho.2020.11.008_bib1180","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/lio2.325","article-title":"Reconstruction of segmental mandibular defects: current procedures and perspectives","volume":"4","author":"Par\u00e9","year":"2019","journal-title":"Laryngoscope Invest Otolaryngol"},{"key":"10.1016\/j.morpho.2020.11.008_bib1185","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/odi.12489","article-title":"Hyperbaric oxygen therapy and osteonecrosis","volume":"23","author":"Ceponis","year":"2017","journal-title":"Oral Dis"},{"key":"10.1016\/j.morpho.2020.11.008_bib1190","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.joms.2008.12.003","article-title":"Utility of hyperbaric oxygen in treatment of bisphosphonate-related osteonecrosis of the jaws","volume":"67","author":"Freiberger","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.morpho.2020.11.008_bib1195","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.joms.2007.03.019","article-title":"Hyperbaric oxygen treatment and bisphosphonate-induced osteonecrosis of the jaw: a case series","volume":"65","author":"Freiberger","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.morpho.2020.11.008_bib1200","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.joms.2012.04.001","article-title":"What is the role of hyperbaric oxygen in the management of bisphosphonate-related osteonecrosis of the jaw: a randomised controlled trial of hyperbaric oxygen as an adjunct to surgery and antibiotics","volume":"70","author":"Freiberger","year":"2012","journal-title":"J Oral Maxillofac Surg"},{"issue":"3","key":"10.1016\/j.morpho.2020.11.008_bib1205","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.bjoms.2019.12.001","article-title":"Effectiveness of laser-assisted treatments for medication-related osteonecrosis of the jaw: a systematic review","volume":"58","author":"Li","year":"2020","journal-title":"Br J Oral Maxillofac Surg"},{"key":"10.1016\/j.morpho.2020.11.008_bib1210","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jcms.2020.01.014","article-title":"Is the application of platelet concentrates effective in the prevention and treatment of medication-related osteonecrosis of the jaw? A systematic review","volume":"48","author":"Fortunato","year":"2020","journal-title":"J Cranio-Maxillofac Surg"},{"key":"10.1016\/j.morpho.2020.11.008_bib1215","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jormas.2019.02.011","article-title":"The use of platelet-rich fibrin in the management of medication-related osteonecrosis of the jaw: a case series","volume":"121","author":"Fernando de Almeida Barros Mourao","year":"2020","journal-title":"J Stomatol Oral Maxillofac Surg"},{"key":"10.1016\/j.morpho.2020.11.008_bib1220","first-page":"629","article-title":"Sur la sensibilit\u00e9 du tissu osseux normal vis-\u00e0-vis des radiations X et sur le m\u00e9canisme de l\u2019ost\u00e9oradion\u00e9crose","volume":"87","author":"Regaud","year":"1922","journal-title":"C R Seances Soc Biol Fil"},{"key":"10.1016\/j.morpho.2020.11.008_bib1225","first-page":"7","article-title":"Osteomyelitis and osteoradionecrosis of the jaws","volume":"26","author":"Titterington","year":"1971","journal-title":"J Oral Med"},{"key":"10.1016\/j.morpho.2020.11.008_bib1230","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/idj.12318","article-title":"Osteoradionecrosis of the jaws: definition, epidemiology, staging and clinical and radiological findings. A concise review","volume":"68","author":"Chronopoulos","year":"2018","journal-title":"Int Dent J"},{"key":"10.1016\/j.morpho.2020.11.008_bib1235","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10006-009-0198-9","article-title":"Osteoradionecrosis of the jaws \u2013 a current overview \u2013 part 1: physiopathology and risk and predisposing factors","volume":"14","author":"Chrcanovic","year":"2010","journal-title":"Oral Maxillofac Surg"},{"key":"10.1016\/j.morpho.2020.11.008_bib1240","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.canrad.2010.03.011","article-title":"Normal tissue tolerance to external beam radiation therapy: the mandible","volume":"14","author":"Berger","year":"2010","journal-title":"Cancer Radioth"},{"key":"10.1016\/j.morpho.2020.11.008_bib1245","series-title":"L\u2019ost\u00e9oradion\u00e9crose mandibulaire: \u00e9valuation de la prise en charge th\u00e9rapeutique au CHU de Nantes MD thesis","first-page":"1","author":"Fauvel","year":"2014"},{"key":"10.1016\/j.morpho.2020.11.008_bib1250","first-page":"17","article-title":"Infectious diseases of the jaws","volume":"28","author":"Meyer","year":"1970","journal-title":"J Oral Surg"},{"key":"10.1016\/j.morpho.2020.11.008_bib1255","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.ijom.2005.07.014","article-title":"Scanning and transmission electron microscopy demonstrates bacteria in osteoradionecrosis","volume":"34","author":"St\u00f8re","year":"2005","journal-title":"Int J Oral Maxillofac Surg"},{"key":"10.1016\/j.morpho.2020.11.008_bib1260","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0278-2391(83)90294-X","article-title":"Osteoradionecrosis: a new concept of its pathophysiology","volume":"41","author":"Marx","year":"1983","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.morpho.2020.11.008_bib1265","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0278-2391(83)80005-6","article-title":"A new concept in the treatment of osteoradionecrosis","volume":"41","author":"Marx","year":"1983","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.morpho.2020.11.008_bib1270","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/0196-0709(90)90084-9","article-title":"Osteoradionecrosis of the mandible: pathogenesis","volume":"11","author":"Bras","year":"1990","journal-title":"Am J Otolaryngol"},{"key":"10.1016\/j.morpho.2020.11.008_bib1275","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.radonc.2004.08.021","article-title":"The radiation-induced fibroatrophic process: therapeutic perspective via the antioxidant pathway","volume":"73","author":"Delanian","year":"2004","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.morpho.2020.11.008_bib1280","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ijom.2018.08.007","article-title":"Management of osteoradionecrosis of the jaws with pentoxifylline-tocopherol: a systematic review of the literature and meta-analysis","volume":"48","author":"Kolokythas","year":"2019","journal-title":"Int J Oral Maxillofac Surg"},{"key":"10.1016\/j.morpho.2020.11.008_bib1285","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1177\/0194599810396290","article-title":"Mandibular osteoradionecrosis in squamous cell carcinoma of the oral cavity and oropharynx: incidence and risk factors","volume":"144","author":"Monnier","year":"2011","journal-title":"Otolaryngol-Head Neck Surg"},{"key":"10.1016\/j.morpho.2020.11.008_bib1290","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1053\/joms.2000.9562","article-title":"Osteoradionecrosis of the jaws: clinical characteristics and relation to the field of irradiation","volume":"58","author":"Thorn","year":"2000","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.morpho.2020.11.008_bib1295","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.surge.2014.07.003","article-title":"The management of osteoradionecrosis of the jaws \u2013 a review","volume":"13","author":"Rice","year":"2015","journal-title":"Surgeon"},{"key":"10.1016\/j.morpho.2020.11.008_bib1300","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s12663-015-0762-9","article-title":"Osteoradionecrosis of the jaws: clinico-therapeutic management: a literature review and update","volume":"14","author":"Nadella","year":"2015","journal-title":"J Maxillofac Oral Surg"},{"key":"10.1016\/j.morpho.2020.11.008_bib1305","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.ijrobp.2019.02.044","article-title":"HOPON (hyperbaric oxygen for the prevention of osteoradionecrosis): a randomised controlled trial of hyperbaric oxygen to prevent osteoradionecrosis of the irradiated mandible after dentoalveolar surgery","volume":"104","author":"Shaw","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"11","key":"10.1016\/j.morpho.2020.11.008_bib1310","article-title":"Interventions for preventing osteoradionecrosis of the jaws in adults receiving head and neck radiotherapy","author":"El-Rabbany","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.morpho.2020.11.008_bib1315","first-page":"e91","article-title":"Osteoradionecrosis of the jaws triggered by dental implants placement: a case report","volume":"11","author":"Toledano-Serrabona","year":"2019","journal-title":"J Clin Exp Dent"},{"key":"10.1016\/j.morpho.2020.11.008_bib1320","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/hed.26065","article-title":"Post-implantation radiation therapy in head and neck cancer patients: literature review","volume":"42","author":"Koudougou","year":"2020","journal-title":"Head Neck"},{"issue":"9","key":"10.1016\/j.morpho.2020.11.008_bib1325","article-title":"Interventions for replacing missing teeth: hyperbaric oxygen therapy for irradiated patients who require dental implants","author":"Esposito","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.morpho.2020.11.008_bib1330","first-page":"336","article-title":"Elimination of sequestrum and healing of osteoradionecrosis of the mandible after hyperbaric oxygen therapy: report of a case","volume":"31","author":"Mainous","year":"1973","journal-title":"J Oral Surg"},{"key":"10.1016\/j.morpho.2020.11.008_bib1335","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0300-9785(74)80066-9","article-title":"Hyperbaric oxygen in total rehabilitation of patients with mandibular osteoradionecrosis","volume":"3","author":"Mainous","year":"1974","journal-title":"Int J Oral Surg"},{"key":"10.1016\/j.morpho.2020.11.008_bib1340","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s10006-010-0205-1","article-title":"Osteoradionecrosis of the jaws \u2013 a current overview \u2013 part 2: dental management and therapeutic options for treatment","volume":"14","author":"Chrcanovic","year":"2010","journal-title":"Oral Maxillofac Surg"},{"key":"10.1016\/j.morpho.2020.11.008_bib1345","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0278-2391(99)90281-1","article-title":"In vitro effects of therapeutic ultrasound on cell proliferation, protein synthesis, and cytokine production by human fibroblasts, osteoblasts, and monocytes","volume":"57","author":"Doan","year":"1999","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.morpho.2020.11.008_bib1350","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0266-4356(92)90181-H","article-title":"The conservative management of osteoradionecrosis of the mandible with ultrasound therapy","volume":"30","author":"Harris","year":"1992","journal-title":"Br J Oral Maxillofac Surg"},{"key":"10.1016\/j.morpho.2020.11.008_bib1355","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jss.2012.03.062","article-title":"Low-intensity ultrasound accelerates mandibular implant bone integration in dogs with mandibular osteoradionecrosis","volume":"182","author":"Wu","year":"2013","journal-title":"J Surg Res"},{"key":"10.1016\/j.morpho.2020.11.008_bib1360","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.joms.2005.10.027","article-title":"Effects of low-intensity pulsed ultrasound on healing of mandibular fractures: an experimental study in rabbits","volume":"64","author":"Erdo\u01e7an","year":"2006","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.morpho.2020.11.008_bib1365","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.joms.2003.06.006","article-title":"Ultrasound to stimulate mandibular bone defect healing: a placebo-controlled single-blind study in rats","volume":"62","author":"Schortinghuis","year":"2004","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.morpho.2020.11.008_bib1370","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s00402-011-1444-9","article-title":"Extracorporeal shock wave therapy in early osteonecrosis of the femoral head: prospective clinical study with long-term follow-up","volume":"132","author":"Vulpiani","year":"2012","journal-title":"Arch Orthop Trauma Surg"},{"key":"10.1016\/j.morpho.2020.11.008_bib1375","first-page":"2380","article-title":"Treatment for osteonecrosis of the femoral head: comparison of extracorporeal shock waves with core decompression and bone grafting","volume":"87","author":"Wang","year":"2005","journal-title":"J Bone Joint Surg"},{"key":"10.1016\/j.morpho.2020.11.008_bib1405","article-title":"Use of shock waves for the treatment of osteonecrosis of the mandible. A non-invasive approach","author":"Choukroun","year":"2020","journal-title":"Implantology"},{"key":"10.1016\/j.morpho.2020.11.008_bib1385","doi-asserted-by":"crossref","first-page":"491e2","DOI":"10.1016\/j.oooo.2019.08.004","article-title":"Systematic review of the use of pentoxifylline and tocopherol for the treatment of medication-related osteonecrosis of the jaw","volume":"128","author":"Heifetz-Li","year":"2019","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1016\/j.morpho.2020.11.008_bib1390","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.ijrobp.2010.03.029","article-title":"Complete restoration of refractory mandibular osteoradionecrosis by prolonged treatment with a pentoxifylline-tocopherol-clodronate combination (PENTOCLO): a phase II trial","volume":"80","author":"Delanian","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.morpho.2020.11.008_bib1395","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.oooo.2019.08.005","article-title":"The effect of combined application of pentoxifylline and vitamin E for the treatment of osteoradionecrosis of the jaws: a meta-analysis","volume":"129","author":"Zhang","year":"2020","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1016\/j.morpho.2020.11.008_bib1400","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.ijom.2019.08.021","article-title":"The need for more robust research on the role of pentoxifylline and tocopherol in the management of osteoradionecrosis of the jaws","volume":"49","author":"Tocaciu","year":"2020","journal-title":"Int J Oral Maxillofac Surg"}],"container-title":["Morphologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1286011520301181?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1286011520301181?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T13:58:40Z","timestamp":1761141520000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1286011520301181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":140,"journal-issue":{"issue":"349","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S1286011520301181"],"URL":"https:\/\/doi.org\/10.1016\/j.morpho.2020.11.008","relation":{},"ISSN":["1286-0115"],"issn-type":[{"value":"1286-0115","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medication-related osteonecrosis and osteoradionecrosis of the jaws: Update and current management","name":"articletitle","label":"Article Title"},{"value":"Morphologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.morpho.2020.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}